◇ China Medical University (Ph.D. candidate)
Seoul University (Visiting Scholar)
◇ >11 years @ Changjiang Capital, Sinopharm, Conba.
◇ Broad experience in investment and operation
◇ Participated in biotech investment & post investment
◇ Certified mutual fund manager.
◇ Member of Pharmaceutical Management Committee,
Zhejiang Pharmaceutical Association
MR. JAROD CHEN
Co-founder & COO
◇ Northwestern Univ. (Ph.D.); RTI (Postdoc)
◇ >30 years @ Pharmacia/Pfizer (Director & Associate
◇ >20 Journal publications; >470 global & regional patents.
◇ Agenerase®, Lexiva®, Prezista® & Xalkori®
PF-04965842 (Phase III), PF-06763809 (Phase Ib)
◇ Distinguished Alumni (2016), Northern Illinois University;
◇ Frequently invited speakers at conferences & universities
MICHAEL VAZQUEZ, Ph.D.
Co-founder, Sr. Vice President & Head of
◇ Kobe Unive. (Ph.D.); UT S.W. Medical Center (postdoc)
◇ >25 years @ Merck, Medicilon
◇ Publications in Nature, PNAS, JBC; >40 US global & regional
◇ Invanz®, KU-2285, AK-2123, Platensimycin & Platencin
◇ Outstanding reviewer for Biochem. Pharmacol. 2015
◇ Leadership Award, Merck, 2003
◇ Distinguished Director, Cancer Institute of CAMS 1989
◇ Editorial Board Members for 3 English Journals
JUN WANG, Ph.D.
Co-founder & CSO
◇ Boston Univ. (Ph.D.), Harvard Univ. (postdoc)
◇ 18 years @ Wyeth/Pfizer, JNJ (Head of Chemistry)
◇ >40 Journal publications; >140 global & regional patents.
◇ HSD-016, HSD-621 & PF-06700841 (Phase II) & HalavenTM
◇ Co-founder, Chinese BioMedical Association (CABA)
◇ Fellow of the Royal Society of Chemistry, RSC, UK
◇ Young Industrial Investigators Award, American Chemical
◇ Steering Committee Member, CICR, AACR
ZHAO-KUI (ZK) WAN, Ph.D., FRSC
Founder, Chairman of the Board & CEO